Being vaccinated against COVID-19 during pregnancy provides protection for the baby through its first several months of life, a Kaiser Permanente analysis finds. Protection was stronger against the delta variant than the more recent omicron variant.
A medication used to treat HIV and to prevent at-risk people from contracting the virus may improve COVID-19 outcomes for both groups, according to research from Kaiser Permanente published in Clinical Infectious Diseases.
A unique Kaiser Permanente study confirms the safety of using blood donated from people who have been vaccinated against or who have had COVID-19.
A large Kaiser Permanente analysis of COVID-19 patients confirms the value of vaccination, finding higher rates of hospitalization and advanced medical care for COVID-19 patients who were unvaccinated, were vaccinated but not boosted, or who had an additional health condition such as obesity or heart disease.
An analysis of Kaiser Permanente members in Northern California early in the COVID-19 pandemic found racial and ethnic disparities in the likelihood of testing positive for the coronavirus, but no significant disparities in mortality among those who were hospitalized.
Division of Research
4480 Hacienda Drive
Pleasanton, CA 94588
Privacy Policy | Terms and Conditions | Your Privacy Choices
Follow us on these external social media sites that will open in a new browser window.
© 2026 Kaiser Permanente Division of Research